Cosmos Health (COSM) Acquisitions (2023 - 2026)
Cosmos Health's (COSM) quarterly Acquisitions came in at $199905.0 in Q2 2026, down 50.0% quarter-over-quarter from $399809.0 in Q1 2026.
Powered by 
Analysis
Cosmos Health (COSM) Acquisitions (2023 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Acquisitions for 2 consecutive years, with $199905.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Acquisitions changed N/A year-over-year to $199905.0; the trailing twelve-month figure through Jun 2026 stood at $599714.0 (changed N/A YoY), and the FY2023 full-year result was -$5.2 million, changed N/A from the prior year.
- Acquisitions slipped to $199905.0 in Q2 2026 per COSM's latest filing, from $399809.0 in the prior quarter.
- Across five years, Acquisitions topped out at $10.6 million in Q3 2023 and bottomed at -$10.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -2.32 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 199,905.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199,905.00 |
| Mar 31, 2026 | 399,809.00 |
| Dec 31, 2023 | -10.46 Mn |
| Sep 30, 2023 | 10.56 Mn |